Chandra M Goparaju
Overview
Explore the profile of Chandra M Goparaju including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsay J, Darawshy F, Wang C, Kwok B, Wong K, Wu B, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Sep;
33(11):1433-1444.
PMID: 39225784
Background: Risk of early-stage lung adenocarcinoma recurrence after surgical resection is significant, and the postrecurrence median survival is approximately 2 years. Currently, there are no commercially available biomarkers that predict...
2.
Smith D, Goparaju C, Pass H, James L, Alimi M, Chang S, et al.
Ann Thorac Surg Short Rep
. 2023 Jun;
PMID: 37360841
Background: Evidence suggests that patients critically ill with COVID-19 have a dysregulated host immune response that contributes to end-organ damage. Extracorporeal membrane oxygenation (ECMO) has been used in this population...
3.
Pass H, Alimi M, Carbone M, Yang H, Goparaju C
Thorac Surg Clin
. 2020 Oct;
30(4):395-423.
PMID: 33012429
Malignant pleural mesothelioma (MPM) is an asbestos-related neoplasm that can only be treated successfully when correctly diagnosed and treated early. The asbestos-exposed population is a high-risk group that could benefit...
4.
Pass H, Alimi M, Carbone M, Yang H, Goparaju C
Cancer Epidemiol Biomarkers Prev
. 2020 Jul;
29(12):2524-2540.
PMID: 32699075
Malignant pleural mesothelioma (MPM) is an asbestos-related neoplasm, which can be treated successfully only if correctly diagnosed and treated in early stages. The asbestos-exposed population serves as a high-risk group...
5.
Napolitano A, Antoine D, Pellegrini L, Baumann F, Pagano I, Pastorino S, et al.
Clin Cancer Res
. 2020 Mar;
26(6):1529.
PMID: 32169964
No abstract available.
6.
Baird A, Easty D, Jarzabek M, Shiels L, Soltermann A, Klebe S, et al.
Front Endocrinol (Lausanne)
. 2019 Mar;
10:89.
PMID: 30863365
Malignant pleural mesothelioma (MPM) is an aggressive inflammatory cancer with a poor survival rate. Treatment options are limited at best and drug resistance is common. Thus, there is an urgent...
7.
Napolitano A, Antoine D, Pellegrini L, Baumann F, Pagano I, Pastorino S, et al.
Clin Cancer Res
. 2016 Jan;
22(12):3087-96.
PMID: 26733616
Purpose: To determine whether serum levels of high mobility group box protein 1 (HMGB1) could differentiate malignant mesothelioma patients, asbestos-exposed individuals, and unexposed controls. Experimental Design: Hyperacetylated and nonacetylated HMGB1...
8.
Blasberg J, Pass H, Goparaju C, Flores R, Lee S, Donington J
J Clin Oncol
. 2010 Jan;
28(6):936-41.
PMID: 20085934
PURPOSE Plasma osteopontin (OPN) levels in advanced non-small-cell lung cancer (NSCLC) correlate with therapeutic response and survival, but the utility of plasma OPN for diagnosis and monitoring of early-stage NSCLC...
9.
Blasberg J, Goparaju C, Pass H, Donington J
J Thorac Cardiovasc Surg
. 2009 Oct;
139(6):1587-93.
PMID: 19818970
Objective: Osteopontin is a multifunctional phosphoprotein with an important but poorly understood role in non-small cell lung cancer pathogenesis. We hypothesize that osteopontin isoforms (OPNa, OPNb, and OPNc) have divergent...
10.
Chen Y, Chien C, Goparaju C, Hsu J, Liang P, Chen X
Protein Expr Purif
. 2004 Mar;
35(1):142-6.
PMID: 15039077
DPP8 is a new member of the prolyl dipeptidases, many of which have important biological functions in vivo. DPP8 catalyzes the cleavage at the carboxyl side of the proline residue...